Leachables and Extractables

Leachables and Extractables

Barcelona, Spain

Course No 17553


Non ECA Member: EUR 2280,--
ECA-Member: EUR 2080,--
EU/GMP Inspectorates: EUR 1140,--
APIC Member Discount: EUR 2180,--

(All prices excl. VAT)

If you have any questions, please contact us:
Tel.: +49 (0)6221 / 84 44 0 E-Mail: info@gmp-compliance.org


Dr J. Susanne Becker, Intertek Switzerland AG
Dr Bettine Boltres, West Pharmaceutical Services GmbH & Co. KG
Lothar Fruth, Toxicology Expert Services
Dr Armin Hauk, Sartorius Stedim Biotech GmbH
Dr Michael Jahn, Lonza AG
Dennis Jenke, Triad Scientific Solutions/USP
Petra Motzkau, Sartorius Stedim Biotech GmbH
Dr Andreas Nixdorf, SGS Institut Fresenius GmbH
Gaby Reckzügel, Boehringer Ingelheim Pharma GmbH & Co. KG
Dr Alicja Sobantka, Octapharma GmbH
Dr Jörg Zürcher, Bayer AG


Over the last years, the requirements on the assessment of substances that could leach into the drug product in the course of its life cycle have increased considerably.

The kind of leachable you would have to look for can vary from organic oligomers and catalyst residues to heavy metals – to name a few. Due to the resulting complexity, it is very important to consider the potential risk factors associated with leaching substances already at a very early stage in process development.

Packaging materials have been in the focus of such investigations for a long time as the contact time between drug product and packaging material is rather long.
But in addition you have also to consider other possible sources of contamination. Recently, particular attention was paid to devices and equipment used in the production process itself, e.g. filters, bags, tubes. The trend towards single-use equipment might relieve the pressure on cleaning validation and the need to introduce control strategies along the supply chain to avoid unintentional added impurities in materials. At the same time leachables/extractables testing will become a topic of major concern.

Within the scope of this GMP Education Course, all relevant aspects of  Pharmacopoeia/GMP-compliant leachables and
extractables testing will be addressed ranging from regulatory requirements to routine extractables testing in quality control.

Experienced industry speakers share their in-depth knowledge with you.

Target Group

The course is designed for personnel of pharmaceutical companies and their suppliers who
  • are responsible for qualification of extractables/
  • leachables in quality control.
  • perform leachables/extractables testing.
  • work in quality control of packaging materials.
  • choose and define polymeric, glass and rubber materials in process development.
  • choose and define Single Use Equipment for manufacturing.
  • develop materials sourcing strategies.


Introduction to Plastics Construction and related Additives
  • Classification of Plastics
  • Physical and chemical characteristics
  • Different types of additives in plastics
Introduction to Extractables and Leachables - Regulations and Recommendations
  • Why should Extractables & Leachables be assessed?
  • Regulatory requirements of EMA and US-FDA
  • Compendial requirements and foodstuff regulations
  • PQRI recommendations and ICH Guidelines: Safety Thresholds and Permitted Daily Exposure
  • USP <1663>, <1664>: Best Practices for Extractables & Leachables testing
Determining the Suitability of Packaging Systems for Therapeutic Products: Compendial Perspective
  • Rationale and current thinking around  USP’s packaging Standards
  • How Chemical Characterization is being integrated into USP packaging Standards
  • Current, and future, changes to USP plastic, glass and elastomeric Standards
  • Chemical Characterization of component used to manufacture drug products
Principle Organisation of E&L Assessments - an Overview; Practical Aspects beyond Theory
  • Extractables & Leachables Study organization for finished packaging’s, timely planning
  • Extractables study designs as part of material qualification and selection
  • Selection of extraction conditions and methods
  • Identification categories, trustable identification
  • Semi-quantitation, analytical uncertainty
  • Analytical methods, target analysis or screening or both
  • Analytical sensitivity adjustment, correlation with analytical evaluation threshold
  • Impacts of sterilization methods on materials chemical composition
Extractables and Leachables Testing in Packaging Material, Correlation between Extractables & Leachables, Leachables Strategies 
  • Analytical method requirements, validation of Leachables analytical methods
  • Development of Leachables strategies based on Extractable profile and toxicological Report
  • How to deal with trustable and poorly characterized chemical profiles
  • How to establish the “chemical link” between Extractables & Leachables
  • Leachables observed only in Leachables study but not in the Extractables study: What to do?
  • OOS case
Extractables and Leachables in Quality Control and Life Cycle Management
  • Batch-to-batch consistency in composition and purity of packaging components
  • Acceptance criteria for extractables/leachables
  • Quality agreements with suppliers
  • Change Management
The Interpretation and Use of Extractables Data; from Extractables Data to Potential Exposure Estimations
  • Physical-chemical principles of extraction versus Extractables protocols
  • The use of extractables data  in Scaling and Combination exercises
  • The use of extractables data in exposure estimations
  • Differences in data interpretation for CCS and SUS
  • Quantitative mitigation concepts for the assessment of SUS
Extractables from Glass
  • Glass composition
  • Type of extractables from glass
  • Risk evaluation of glass extractables
  • Concepts to avoid extractables from glass
Including Elastomeric Closures in Extractables/Leachables Assessment
  • Composition of Elastomers used for Pharmaceutical Applications
  • Discussion Material Composition and Extractables (Potential Extractable List)
  • Approaches to minimize Extractable/ Leachable from Elastomeric Closures
  • Case Study presentation
What do the Analytical Results mean?  The Toxicologist as Interpreter
  • Expectations to the toxicologist
  • Prerequisites for a successful toxicological risk assessment
  • Criteria for the quality check of a toxicological risk assessment
  • QSAR tools and TTC concept -can they replace a toxicologist?
In the course of this workshop you will develop a strategy for conducting a compliant and reasonable leachables studies.
The task will be based on an industry example.
It will be your challenge to answer the following questions:
  •  Which activities are necessary during the development phase?
  •  How will you deal with quality control during routine production?
  •  Where will you find useful information about the material you are going to use?
A reasonable E&L Design for Complex Products
  •  Summary of the different steps to be addressed for a proper Extractables-Leachables Screening Study
  •  Illustration of different study designs which may be applied for complex materials consisting of many different parts
  •  Importance of a Leachables check experiment as part of the formal Extractables screening study
  •  Case studies/examples of complex materials, such as, nasal spray device, multilayer bag from single use dosage system
USP Strategy for developing Standard for Plastic Components and Systems used on the Manufacturing of a Drug Product
  •  Objective of standard
  •  Risk based approach outlined in the standard
  •  Rationale for solvent chosen for standards
Leachables during Manufacturing
  • Single-Use process equipment (e.g. filters, bags)
  • Risk-based evaluation and testing strategies under consideration of critical success factors for the pharma/biotech industry such as cost efficiency, time-to-market and regulatory compliance
Interference of Leachables with Biopharmaceuticals during Manufacturing, Storage and Administration
  •  Influence of leachables on biopharmaceutical process performance
  •  Influence of leachables on the stability of biopharmaceuticals
  •  Influence of leachables on the analytics of biopharmaceuticals
E&L Assessment for Biologic Combination Products. The Pharmaceutical Manufacturer’s Perspective
  • Limits of Regulatory
  • Challenges in extractables profiling
  • Case studies
  • Medical devices / combination products
In this workshop you will handle examples of Leachables studies in the field of  biopharmaceutical manufacturing.These examples will base on industrial and contract lab issues and challenges relating to modern process strategies

Go back

GMP Conferences by Topics

Cookies help us in providing our services. By using our services, you agree that we use cookies. Further information